Mostrar el registro sencillo del ítem

dc.contributor.author
Ciapponi, Agustín  
dc.date.available
2021-12-06T12:06:02Z  
dc.date.issued
2019-08  
dc.identifier.citation
Ciapponi, Agustín; For people with osteoarthritis, how does tramadol compare with other analgesics?; Wiley; Cochrane Clinical Answers; 8-2019; 1-18  
dc.identifier.issn
2050-4217  
dc.identifier.uri
http://hdl.handle.net/11336/148233  
dc.description.abstract
For people with knee or hip osteoarthritis, tramadol was slightly less effective than non‐steroidal anti‐inflammatory drugs (NSAIDs) regarding pain, physical function, and adverse events. Compared with other opioids, tramadol slightly improved physical function but resulted in little to no difference in pain and increased withdrawals due to adverse events.Moderate‐certainty evidence shows that people with hip or knee osteoarthritis had slightly more pain with tramadol than with NSAIDs but reported little to no difference in pain between tramadol and other opioids. Physical function was slightly worse with tramadol than with NSAIDs (low‐certainty evidence), but more people had improved physical function with tramadol than with other opioids (667 vs 505 per 1000 people; all results on average; moderate‐certainty evidence). Moderate‐certainty evidence shows that more people will probably experience an adverse event with tramadol than with NSAIDs (774 vs 591 per 1000 people; based on 128 people), but very low‐certainty evidence suggests little to no difference compared with other opioids. Low‐certainty evidence suggests that more people withdrew from treatment due to an adverse event with tramadol than with NSAIDs or other opioids (186 vs 99 per 1000 people and 246 vs 109 per 1000 people, respectively). The effect of tramadol compared with NSAIDs or other opioids on serious adverse events was uncertain, but event rates were very low in all groups (≤ 3%). Reviewers found little to no difference in symptoms of opioid dependence between tramadol and NSAIDs, but this assessment was based on only 97 participants. No conclusions could be drawn for the comparison of tramadol versus paracetamol, as this was assessed in an RCT with only 20 participants.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Wiley  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
SALUD  
dc.subject.classification
Otras Ciencias de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
For people with osteoarthritis, how does tramadol compare with other analgesics?  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2021-01-04T14:29:00Z  
dc.journal.pagination
1-18  
dc.journal.pais
Reino Unido  
dc.description.fil
Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina  
dc.journal.title
Cochrane Clinical Answers  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://doi.wiley.com/10.1002/cca.2636  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/cca.2636